Updated Guideline for Management of Lower Extremity Peripheral Artery Disease

This update of the 2016 guideline includes new options for medical therapies and a focus on health disparities.

Sponsoring Organizations: American College of Cardiology and American Heart Association

Target Audience: Primary care clinicians, vascular medicine specialists, cardiovascular specialists, interventional radiologists, vascular surgeons, podiatrists, wound care specialists

Background and Objectives

This update to the 2016 guideline provides recommendations for managing patients across the spectrum of peripheral artery disease (PAD) presentation (asymptomatic to limb ischemia).

What's Changed

Low-dose rivaroxaban, in addition to daily aspirin, is now recommended to decrease the risk for major adverse cardiovascular events (MACEs) and major adverse limb events in patients with symptomatic PAD who are not at increased bleeding risk.
In patients with …

Reviewing Author

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM

Disclosures

Editorial BoardsVascular Medicine